1
Li H#, Liu J#, Fang Q#, Li Z#, Guo C#, Chen Y#, Fan G#, Zhang Q#, Hua Z, Lv D, Tang L, Hou B, Cao B*. Pathogen-specific immunity debt in children after prolonged nonpharmaceutical interventions: a cross-sectional study in China. Int J Infect Dis. 2026 Feb;163:108278. doi: 10.1016/j.ijid.2025.108278. Epub 2025 Dec 3. PMID: 41349865.
2
Pu D, Zhuo X, Song R, Wang C, Zhao J*, Cao B*. EnvZ mutation-driven downregulation of catecholate siderophore receptors and concurrent TonB complex repression confer cefiderocol resistance in a KPC-producing ST11-KL64 hypervirulent Klebsiella pneumoniae. Int J Antimicrob Agents. 2026 Feb;67(2):107693. doi: 10.1016/j.ijantimicag.2025.107693. Epub 2025 Dec 18. PMID: 41421567.
3
Yan M#, Wang N#, Yang L, Zhang X, Zhang Y, Xuan W, Zhang X, Liu G, Wang H, Qing Y, Wang Y*, Cao B*. Myxovirus resistance protein A to differentiate between viral and non-viral respiratory infections in adults: a prospective study. Emerg Microbes Infect. 2026 Dec;15(1):2614734. doi: 10.1080/22221751.2026.2614734. Epub 2026 Jan 16. PMID: 41544183; PMCID: PMC12818327.
4
Liu H#, Zheng Y#, Deng X#, Li M, He D, Zuo W, Xu Y, Shen X, Li H*, Cao B*. Molecular Classification of Patients With COVID-19 Based on Transcriptional Profiling. Influenza Other Respir Viruses. 2026 Feb;20(2):e70227. doi: 10.1111/irv.70227. PMID: 41664599; PMCID: PMC12887440.
5
Sun L#, Wang Y#, Fang J, Li Z, Yin Y, Guo Y, Wang Q, Chen H, Cao B, Wang H*. Clinical experience with metagenomic next-generation sequencing (mNGS) for the detection of Tropheryma whipplei in respiratory specimens: A multicenter retrospective observational study. Int J Infect Dis. 2026 Feb 5;165:108457. doi: 10.1016/j.ijid.2026.108457. Epub ahead of print. PMID: 41654251.
6
He D#, Zuo W#, Xiang Z#, Zhao J#, Tong W, Li H, Fang Q, Li X, Zhang Y, Zheng Y, Zhuo X, Pu D, Huang Y, Yuan Y, Wang W, Lu Y, Luo M, Wang P, Wang Z*, Cao B*. Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling. Nat Commun. 2026 Mar 9. doi: 10.1038/s41467-026-70095-x. Epub ahead of print. PMID: 41803143.
7
Wang C#, Chang K#, Chen M#, Zou X#, Ni Y, Zhang Q, Zhao L, Xing B, Guo L, Chen W*, Cao B*. Enrichment of the commensal microbiome in the lower respiratory tract is associated with improved outcomes following lung transplantation. Chin Med J Pulm Crit Care Med. 2025 Dec 12;3(4):308-318. doi: 10.1016/j.pccm.2025.11.006. PMID: 41551013; PMCID: PMC12805393.
8
Yan M#, Gu X#, Wang Y, Cao B*. Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor vs Neuraminidase Inhibitor in High-risk Patients Hospitalized With Severe Influenza: A Post Hoc Analysis of the Flagstone Trial. Open Forum Infect Dis. 2025 Jul 25;12(8):ofaf439. doi: 10.1093/ofid/ofaf439. PMID: 40852135; PMCID: PMC12368417.
9
Hong L#, Suo L#, Chang K#, Cao H, Luan J, Zhang F, Yu X, Zou X, Liu B*, Cao B*; CAP-China Network. Longitudinal profiling of host response and oropharyngeal respiratory microbiome reveals dynamic alterations during recovery from community-acquired pneumonia. Biosaf Health. 2025 May 15;7(3):152-165. doi: 10.1016/j.bsheal.2025.05.004. PMID: 40693035; PMCID: PMC12276579.
10
Yang X, Lin W, Zhao Y, Zhao C, Zhou F, Wang D, Yue Z, Pei L, Jia M, Cao B, Cao LL, Wang H. Development and validation of a LC-MS/MS method for the simultaneous determination of simnotrelvir and ritonavir in human serum and bronchoalveolar lavage fluid. BMC Chem. 2025 Jul 2;19(1):180. doi: 10.1186/s13065-025-01534-x. PMID: 40605057; PMCID: PMC12224748.
11
Xu JF, Liu Y, Zhang P, Cao B*. From symptom relief to household control: baloxavir redefines antiviral strategies for influenza. Lancet Reg Health West Pac. 2025 Aug 2;61:101651. doi: 10.1016/j.lanwpc.2025.101651. PMID: 40799772; PMCID: PMC12341615.
12
Wang Y#, Shang L#, Wu L#, Wang X#, Ding B, Hu K, He Y, Li G, Zhai J, Hu J, Tian Y, Wang J, Yan L, Liu B, Song G, He Y*, Wang C*, Cao B*. The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial. Nat Commun. 2025 Aug 7;16(1):7272. doi: 10.1038/s41467-025-62214-x. PMID: 40775020; PMCID: PMC12332093.
13
Zou X#, Cao H#, Hong L, Suo L, Wang C, Chang K, Ni Y, Liu B*, Cao B*. Enrichment of Streptococcus oralis in respiratory microbiome enhance innate immunity and protects against influenza infection. Signal Transduct Target Ther. 2025 Aug 27;10(1):272. doi: 10.1038/s41392-025-02365-x. PMID: 40858544; PMCID: PMC12381301.
14
Wang Q#, Zhang Y#, Yao X, Wang C, Chen S, Liu B, Sun L, Zou X*, Cao B*. Distinct microbiome variation in children and adults following RSV infection and its association with host response. Microb Pathog. 2025 Dec;209:108075. doi: 10.1016/j.micpath.2025.108075. Epub 2025 Sep 29. PMID: 41033368.
15
Shang X#, Jia J, Yu J, Zou S, Wang Z, Xu J, Li H*, Cao B*. Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase. Respir Res. 2025 Oct 8;26(1):285. doi: 10.1186/s12931-025-03359-7. PMID: 41063200; PMCID: PMC12509380.
16
Xu Y#, Zheng Y#, Liu Y#, Wei C#, Ren J, Zuo W, Gu R, Liu H, Deng X, Liu Y, Shang X, Ge W, Li Z, Huang Y, He D, Shen X, Wang Z, Lyu C, Wang Z, Mu Y, Zhang Z, Wu H*, Li H*, Cao B*. Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection. Signal Transduct Target Ther. 2025 Sep 23;10(1):307. doi: 10.1038/s41392-025-02391-9. PMID: 40983621; PMCID: PMC12454662.
